Gemcitabine Impurity 30 | CAS 866473-33-8 - Request Quote
Gemcitabine Impurity 30
| SZ CAT No: | SZ-G007050 |
| CAS No | 866473-33-8 |
| Mol.F. | C19H16F2O7 |
| Mol.Wt. | 394.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Gemcitabine Impurity 30 is chemically 3,5-Bis(benzoyloxy)-2,2-difluoro-4-hydroxypentanoic acid. Gemcitabine Impurity 30 is supplied with detailed characterization data compliant with regulatory guideline. Gemcitabine Impurity 30 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Gemcitabine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 866473-33-8
Purchase 866473-33-8
Order 866473-33-8
Enquire 866473-33-8
price of 866473-33-8
866473-33-8 Supplier
866473-33-8 Manufacturer
866473-33-8 Exporter
buy high quality Gemcitabine Impurity 30
Purchase Gemcitabine Impurity 30
Gemcitabine Impurity 30 suppliers
Gemcitabine Impurity 30 manufacturers
Gemcitabine Impurity 30 price
Order Gemcitabine Impurity 30
Enquire Gemcitabine Impurity 30
Gemcitabine Impurity 30 cost
Gemcitabine Impurity 30 Supplier
Gemcitabine Impurity 30 Distributor
Gemcitabine Impurity 30 for Method Validation
Gemcitabine Reference Standard
Gemcitabine Impurity 30 for ANDA Filing
Gemcitabine Impurity 30 for Forced Degradation Studies
Gemcitabine Impurity 30 Identification Standards
Gemcitabine Impurity 30 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.